siRNA
-
Amsbio: Easy and Economic Generation of Functional siRNAs
The Turbo Dicer siRNA Generation Kit from Amsbio enables the easy and cost-effective generation of a large number of small interfering Ribonucleic Acid (siRNAs) from full-length target genes. siRNAs are 21- to 23-nucleotide RNA molecules that can …
siRNA | 17 May 2010
-
Polyplus-Transfection Introduces Transfection Reagent
Polyplus-transfection has introduced jetPrime – a versatile and powerful Deoxyribonucleic Acid (DNA) and small interfering Ribonucleic Acid (siRNA) transfection reagent for day-to-day experiments, transient expression studies as well as RNA in…
siRNA | 01 October 2009
-
Sigma-Aldrich Develops Approach for RNAi Screening
Sigma-Aldrich has announced the global release of Mission esiRNA, a pool of gene-specific interfering RNA (siRNA) that provides an approach to Ribonucleic Acid interference (RNAi) screening in mammalian cells. Unlike traditional synthetic Ribonucleic…
siRNA | 06 May 2009
-
Transfection Reagent for siRNA Delivery
INTERFERin is a new-generation small interfering Ribonucleic acid (siRNA) transfection reagent that achieves over 90% silencing efficiency at 1 nM siRNA in a variety of adherent and primary cells with cell viability. Using low siRNA concentrations av…
siRNA | 01 October 2008
-
Clinical Trial to Treat Rare Skin Disorder With siRNA Technology
PC Project, a public charity, announced that a Phase 1b clinical trial began today for treatment of pachyonychia congenita (PC) with a short interfering RNA (siRNA)-based therapeutic. PC is a dominant genetic disorder resulting from mutations in gene…
siRNA | 31 January 2008
-
Calando Pharmaceuticals selects Agilent Technologies for siRNA production
Calando Pharmaceuticals Inc., a majority-owned subsidiary of Arrowhead Research Corporation, has selected Agilent Technologies to manufacture the active siRNA component in its lead RNAi product, CALAA01. Calando was formed in 2005 to create, develop …
siRNA | 14 August 2006
